Parabrachial Nucleus In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The Parabrachial Nucleus (PBN) is a critical brainstem structure located in the dorsolateral pons that serves as a major relay for visceral information. It receives input from the nucleus of the solitary tract (NTS) and processes information related to autonomic control, pain, taste, and respiratory function. In neurodegenerative diseases, particularly Parkinson's disease and multiple system atrophy, the PBN is affected both directly and indirectly, contributing to dysautonomia, respiratory dysfunction, and pain syndromes that significantly impact patient quality of life.
¶ Anatomy and Connectivity
¶ Location and Subdivisions
The Parabrachial Nucleus is divided into several subregions:
- Medial Parabrachial Nucleus (PBM): Primary relay for visceral sensation
- Lateral Parabrachial Nucleus (PBL): Gustatory processing and reward
- Superior Lateral Subnucleus: Respiratory control
- Kolliker-Fuse Nucleus: Pneumotaxic center, breathing regulation
- External Subnucleus: Pain and autonomic integration
The PBN receives major inputs from:
The PBN projects to:
The PBN is significantly affected in PD:
- Cardiovascular dysfunction: orthostatic hypotension, supine hypertension
- Thermoregulatory failure: hyperhidrosis, hypothermia
- Gastrointestinal dysfunction: dysphagia, gastroparesis
- Urinary dysfunction: urgency, retention
- Sleep-disordered breathing
- Reduced chemosensitivity to CO2
- Upper airway obstruction
- Pneumonia risk (leading cause of mortality)
- Altered pain perception in PD
- Both hyperalgesia and hypoesthesia observed
- Central pain syndromes
- Musculoskeletal pain from rigidity
The PBN shows prominent degeneration in MSA:
- Severe orthostatic hypotension
- Urinary dysfunction
- erectile dysfunction
- Respiratory stridor
- REM sleep behavior disorder
- Central sleep apnea
- Nocturnal hypoventilation
PBN involvement in ALS:
- Early compromise of respiratory centers
- Reduced ventilatory response to hypoxia/hypercapnia
- Contributes to disease mortality
¶ Pain and Sensory Changes
- Small fiber neuropathy involvement
- Autonomic dysfunction
- Hyperalgesia in some patients
While primarily a cortical disease, AD affects PBN:
- Circadian rhythm disturbances
- Reduced arousal
- Sleep fragmentation
- Cardiovascular dysregulation
- Thermoregulatory impairment
- α-Synuclein: Lewy body pathology in PBN of PD patients
- Tau: Neurofibrillary tangles in AD
- TDP-43: In ALS and frontotemporal dementia
- Reduced catecholaminergic neurons
- Cholinergic dysfunction
- Altered glutamate signaling
- GABAergic alterations
- Microglial activation in PBN
- Cytokine elevation
- Astrocytic reactivity
-
20 mmHg drop in systolic BP
-
10 mmHg drop in diastolic BP
- 3+ minutes after standing
- Contributing factors: sympathetic denervation, baroreflex failure
- Elevated BP when recumbent
- Complicates treatment of orthostatic hypotension
- Due to baroreflex impairment
- Reduced HRV in PD
- Predicts disease progression
- Indicates autonomic neuropathy
- Obstructive sleep apnea
- Central sleep apnea
- Cheyne-Stokes breathing
- Reduced respiratory drive
- Dysphagia and aspiration
- Impaired cough reflex
- Reduced mucociliary clearance
- Burning, aching quality
- Often in distal extremities
- May precede motor symptoms
- Rigidity-related
- Dystonia-associated
- Postural abnormalities
- Reduced PBN binding in PET
- Altered autonomic function tests
- Heart rate variability analysis
- Tilt-table testing for orthostatic hypotension
- Heart rate variability
- Respiratory function tests
- Polysomnography
- Midodrine (α1-agonist)
- Fludrocortisone (mineralocorticoid)
- Pyridostigmine (acetylcholinesterase)
- Droxidopa (L-DOPS)
- Modafinil for excessive daytime sleepiness
- CPAP/BiPAP for sleep apnea
- Respiratory training
- PBN as potential target
- For dysautonomia
- Experimental in PD
- Increased salt and fluid intake
- Compression stockings
- Head-of-bed elevation
- Avoid large meals
Parabrachial Nucleus In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Parabrachial Nucleus In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Jellinger KA. Neuropathology of Parkinson's disease (2023)
- Kalia LV, Lang AE. Parkinson's disease (2022)
- Fanciulli A, et al. Multiple system atrophy (2020)
- Benarroch EE. Autonomic failure in neurodegenerative diseases (2021)
- Cortelli P, et al. Parabrachial nucleus in autonomic dysfunction (2019)
- Pfeffer RF. Gastrointestinal, urinary, and pulmonary dysfunction in PD (2021)